Researcher of the Month is a series started in January 2023 where FCI's researchers are introduced.
July 2026
From Computational Immunology to Cancer Discovery: The Journey of Ming Wu
Pink Ribbon Cancer Researcher Ming Wu is originally from Xiantao, a small city near Wuhan in China. After completing her bachelor’s degree, she moved to Bonn, Germany to pursue a master’s degree in life science informatics. Driven by a growing interest in integrating biology with computational methods, she continued her studies at the Technical University of Munich, where she earned a Ph.D. in computational immunology.
Following her doctoral work, Ming joined Bayer AG in Berlin as a bioinformatics scientist, contributing to cutting-edge research on in vivo CAR-T cell therapies. After nearly a decade in Germany, she sought a new environment that would offer both professional growth and a fresh cultural perspective. A visit to Helsinki in November 2024 became a pivotal moment, inspiring her to begin the next chapter of her scientific journey in Finland.
Unraveling Cancer Immunity: Research Focus and Scientific Motivation
Ming’s research centers on the complex interplay between the immune system and cancer, with a particular emphasis on T cell biology. Her current work investigates the potential link between T cell senescence and chemotherapy resistance in ovarian cancer. She aims to better understand how immune cells and the tumor microenvironment shape disease progression and influence treatment outcomes, ultimately seeking new molecular and cellular targets to improve cancer therapies.
Ming’s interest in cancer immunology was sparked during her time at Bayer AG, where she worked extensively on CAR-T cell therapy. By analyzing patient data and examining tumor microenvironment, Ming realized that successful cancer treatment requires more than targeting tumor cells alone—it also depends on restoring the immune system’s capacity to fight cancer. This insight led her to pursue research at the intersection of computational biology, immunology, and translational science, with the goal of generating discoveries that can make a real difference for patients.
Discovering Hidden T Cell States: Current Research in Ovarian Cancer
In her current research, Ming applies computational methodologies to study single-cell RNA-sequencing data derived from cancer patients with high-grade serous carcinoma (HGSC), an aggressive form of ovarian cancer. Through comprehensive analysis, she has identified a distinct population of tumor-infiltrating T cells.
These cells exhibit a phenotype associated with chronic stress and senescence, rather than the more widely studied exhausted T cell state. Importantly, this unique T cell population appears to be more prevalent in patients with poorer clinical outcomes. Building on these findings, Ming and her collaborators are now designing experiments to validate these observations, uncover the biological mechanisms, and explore its potential as a new therapeutic target.
Shaping the Future of Immunotherapy: Insights from a Nature Publication
One of Ming’s recent publications, “Precursors of exhausted T cells are pre-emptively formed in acute infection,” published in Nature in January 2025, provides important insights into immune cell development. The study focuses on how CD8+ T cells differentiate during the early stages of acute and chronic infections, revealing that the groundwork for T cell exhaustion can be established very early in the immune response.
This discovery advances our understanding of how immune dysfunction arises and persists. From a clinical standpoint, it opens new possibilities for improving cancer immunotherapy by identifying opportunities to intervene before T cells lose their effectiveness. Such strategies could help enhance the immune system’s ability to combat tumors more efficiently.
Beyond the Lab: Discipline, Creativity, and a “Sci-Fi Drummer” Dream
Outside of her scientific work, Ming has cultivated a range of personal interests that reflect both discipline and creativity. Earlier in life, she practiced taekwondo, which helped shape her perseverance and focus. In recent years, she has shifted her attention to swimming and playing drums.
Blending imagination with her scientific mindset, Ming aspires to become a “sci-fi drummer” one day. This ambition captures her curiosity, creativity, and enthusiasm for exploring new dimensions of life beyond research.
Pink Ribbon Cancer Researcher Ming Wu investigates the potential link between T cell senescence and chemotherapy resistance in ovarian cancer.